Disparities in prostate cancer mortality and clinical trial availability across vulnerable populations.

被引：0
|
作者：
Sekar, Rishi
Morgan, Todd Matthew
Wallner, Lauren P.
Stensland, Kristian
Herrel, Lindsey A.
机构：
[1] Univ Michigan, Ann Arbor, MI USA
[2] Univ Michigan, Dept Urol, Ann Arbor, MI USA
来源：
JOURNAL OF CLINICAL ONCOLOGY | 2024年 / 42卷 / 4_SUPPL期
关键词：
261-492-574; 130-11182; 127-936-986; 613-135-444; 7; 5; 3;
D O I：
10.1200/JCO.2024.42.4_suppl.24
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
引用
收藏
页码：24 / 24
页数：1
相关论文
共 50 条
  • [41] Identifying patients at risk for prostate-cancer-specific mortality: implications for clinical trial design
    Andrew J Stephenson
    Nature Clinical Practice Urology, 2007, 4 : 362 - 363
  • [42] Identifying patients at risk for prostate-cancer-specific mortality: implications for clinical trial design
    Stephenson, Andrew J.
    NATURE CLINICAL PRACTICE UROLOGY, 2007, 4 (07): : 362 - 363
  • [43] INTERCEPTING POOR OUTCOMES: AN INNOVATIVE CLINICAL APPROACH FOR REDUCING MENTAL HEALTH DISPARITIES AMONG VULNERABLE POPULATIONS
    Grimes, Katherine E.
    Fritz, Gregory K.
    JOURNAL OF THE AMERICAN ACADEMY OF CHILD AND ADOLESCENT PSYCHIATRY, 2020, 59 (10): : S56 - S56
  • [44] Colorectal cancer model of health disparities: Understanding mortality differences in minority populations
    Polite, Blase N.
    Dignam, James J.
    Olopade, Olufunmilayo I.
    JOURNAL OF CLINICAL ONCOLOGY, 2006, 24 (14) : 2179 - 2187
  • [45] CARET: The beta carotene and retinol efficacy trial for the chemoprevention of lung cancer in high risk populations.
    Goodman, GE
    Omenn, GS
    Thornquist, MD
    JOURNAL OF CLINICAL ONCOLOGY, 1996, 14 (05) : 2023 - 2023
  • [46] Characterization and Clinical Relevance of ALDHbright Populations in Prostate Cancer
    Le Magnen, Clementine
    Bubendorf, Lukas
    Rentsch, Cyrill A.
    Mengus, Chantal
    Gsponer, Joel
    Zellweger, Tobias
    Rieken, Malte
    Thalmann, George N.
    Cecchini, Marco G.
    Germann, Markus
    Bachmann, Alexander
    Wyler, Stephen
    Heberer, Michael
    Spagnoli, Giulio C.
    CLINICAL CANCER RESEARCH, 2013, 19 (19) : 5361 - 5371
  • [47] DISPARITIES IN THE AVAILABILITY OF NEURO-ONCOLOGY CLINICAL TRIAL SUPPORTING INFRASTRUCTURE IN THE UNITED STATES
    Kim, Yeonju
    Armstrong, Terri
    Gilbert, Mark
    Celiku, Orieta
    NEURO-ONCOLOGY, 2023, 25
  • [48] The clinical implications of the Prostate Cancer Prevention Trial
    Marberger, M
    Adolfsson, J
    Borkowski, A
    Fitzpatrick, J
    Kirk, D
    Prezioso, D
    Rabaça, C
    Solsona, E
    Teillac, P
    BJU INTERNATIONAL, 2003, 92 (07) : 667 - 671
  • [49] Prostate cancer vaccine failed clinical trial
    不详
    HUMAN VACCINES & IMMUNOTHERAPEUTICS, 2017, 13 (03) : 492 - 492
  • [50] Trends and Disparities in Prostate Cancer Mortality in the United States (1999-2020)
    Aziz, Nouman
    Nabi, Waseem
    Khan, Muzamil
    Bin Gulzar, Abu Huraira
    Rath, Shree
    Ansab, Muhammad
    Kumar, Danisha
    Bhat, Adnan
    CLINICAL GENITOURINARY CANCER, 2025, 23 (02)
12345